Device Firms Garner 31% Of Venture-Backed Health Care Funding In Q2
This article was originally published in The Gray Sheet
Aggregate investments of $250 mil. in medical device and instrument companies by venture capital firms during the second quarter represented 31% of the nearly $800 mil. in total health care financings in the three months ended June 30, according to a recent PricewaterhouseCoopers Money Tree Survey.
You may also be interested in...
Device start-ups with limited prospects for completing an initial public offering and becoming a stand-alone operation should implement an organizational structure and financing strategy with an eye towards an acquisition exit, Allan May, president and CEO of Intella Interventional Systems advised.
Vasca says it expects to commercialize its LifeSite hemodialysis access system in the U.S. by the end of 1999.
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.